Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (5) | B (2) | C (4) | D (4) | E (8) | F (1) | G (4) | I (3) | L (3) | N (1) | O (2) | P (2) | R (1) | S (6) | T (7) | U (1) | V (1) | W (2)
Generic Name Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)sort icon
Ulipristal Fibristal Selective progesterone receptor modulator (SERM)
Tepotinib Tepmetko Protein kinase inibitor (antineoplastic agent)
Entrectinib Rozlytrek Antineoplastic agent
Apalutamide Erleada Anti-androgen 2018/07/27
Ribociclib Kisqali Antineoplastic agent 2018/11/26
Lorlatinib Lorbrena Tyrosine kinase inhibitor 2019/04/22
Dacomitinib Vizimpro Tyrosine kinase inhibitor 2019/04/22
Cemiplimab Libtayo Antineoplastic agent 2019/05/24
Abemaciclib Verzenio Protein kinase inhibitor 2019/07/03
Larotrectinib Vitrakvi Antineoplastic agent 2019/07/10
Galcanezumab Emgality CGRP binding antibody 2019/10/02
Sodium zirconium cyclosilicate Lokelma Potassium binder 2019/10/17
Edaravone Radicava Treatment for amyotrophic lateral sclerosis 2019/10/29
Glucagon Baqsimi Hyperglycemic agent 2019/11/20
Axicabtagene ciloleucel Yescarta Antineoplastic agent 2019/11/27
Erdafitinib Balversa Protein kinase inhibitor 2019/12/09
Niraparib Zejula Antineoplastic agent 2020/01/09
Gilteritinib Xospata Antineoplastic agent 2020/02/03
Baloxavir marboxil Xofluza Antiviral agent 2020/02/19
Patiromer Veltassa Potassium binder 2020/03/09
Alpelisib Piqray Antineoplastic agent 2020/03/11
Cabotegravir Vocabria Antiretroviral agent 2020/03/19
Cabotegravir + rilpivirine Cabenuva Antiretroviral agent 2020/03/19
Darolutamide Nubeqa Anti-androgen 2020/03/24
Tafamidis Vyndaqel Selective stabilizer of transthyretin - cardiac drug 2020/04/07
Semaglutide Rybelsus Incretin mimetic 2020/04/19
Warfarin Coumadin Anticoagulant 2020/04/23
Siponimod Mayzent Immunomodulatory agent 2020/04/24
Brolucizumab Beovu Antineovascularisation agent 2020/05/15
Esketamine Spravato Antidepressant 2020/05/20
Infliximab Avsola Biological response modifier 2020/06/01
Sonidegib Odomzo Antineoplastic agent 2020/06/11
Apomorphine Kynmobi Nonergot-derivative dopamine receptor agonist 2020/06/12
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Sumatriptan + naproxen Suvexx Serotonin receptor agonist + NSAID 2020/07/24
Tibolone Tibella Hormone replacement therapy 2020/07/29
Syndicate content